Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost
- 30 November 1993
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 49 (5) , 839-845
- https://doi.org/10.1016/0952-3278(93)90207-d
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- Mediators produced by the endothelial cell.Hypertension, 1988
- Endothelium-derived relaxing factorBiochemical Pharmacology, 1988
- The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBritish Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Prostacyclin and arterial wall biology.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976